VNO Stock Recent News

VNO securing of lease expansion with Medline at THE MART, Chicago, highlights healthy demand for the office-space building.

Medline's 161,000 SF Lease Makes the Growing Healthcare Company One of THE MART's Largest Tenants Medline's 161,000 SF Lease Makes the Growing Healthcare Company One of THE MART's Largest Tenants

VNO's premium assets in select high-rent markets, portfolio-repositioning efforts and a healthy balance sheet augur well. However, high-interest expense ails.

Vornado (VNO) reported earnings 30 days ago. What's next for the stock?

Vornado (VNO) is well-poised to gain from tenants' healthy demand for premier office spaces despite a high interest rate environment.

Vornado Realty Trust finished the second quarter with around $1.12 billion in cash, cash equivalents, restricted cash, and short-term investments. The REIT grew FFO by 2 cents over its prior first quarter as quarterly interest expense surged. Pending Fed rate cuts should benefit VNO immensely as the REIT looks to address its 2025 debt maturities.

Vornado Realty's (VNO) properties are poised to draw in tenants on the back of the strong demand for premier office spaces. However, elevated interest rates continue to be a concern.

Vornado (VNO) experiences decent leasing activity and higher initial rent in Q2.

Although the revenue and EPS for Vornado (VNO) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Vornado (VNO) came out with quarterly funds from operations (FFO) of $0.57 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to FFO of $0.72 per share a year ago.